cell therapy fellowship

 

 

 

 

 

Image:  Facultad de Medicina – Universidad de Buenos Aires

ISSCA will host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium in Buenos Aires, Argentina, August 24, 2018.

MIAMI, March 18, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium. In Buenos Aires, Argentina August 24, 2018.

The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. The Buenos Aires event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.

Topics of focus at the symposium include:

  • Management of aging at the cellular level
  • Stem cell therapies in medical aesthetics: the latest methods of harvest and isolation Non-invasive protocols of non-surgical facial and body rejuvenation
  • Beyond fillers and toxins
  • Combined treatment plans that include surgical methods for the management of advanced aging
  • Restoration and assisted hair transplantation with biomaterials and growth factors
  • The invaluable role of biological cosmeceutical in the management of aging
  • The aging process from the inside out: the role of hormones
  • Management of the latest digital marketing tools for recruiting patients in their aesthetic clinics

The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.

The event will be held at the Facultad de Medicina – Universidad de Buenos Aires

To learn more about the ISSCA Buenos Aires symposium and to make a reservation, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA Buenos Aires Regenerative Medicine Symposium

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

ISSCA Founder Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D. to speak at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.

MIAMI, March 18, 2018—ISSCA Founder and General Director Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D. will be keynote speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Kim will discuss stem cell therapies for diabetes, and Gilani will speak on the effect of autologous bone marrow-derived stem cells treatments on knee osteoarthritis.

advisory board, Global Stem Cells Group

Daeyong Kim, Ph.D.

Kim, a Global Stem Cells Group Advisory Board member, is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment and leader of stem cell technology solutions for providers worldwide.

Additionally, Kim is vice-president of BioChip Society, CEO of GTOP Construction Inc, managing director Woojoo Telecom, and managing director of KEPCO KDN.

In 2013, Kim completed an international business course at UC Berkeley, U.S. and received and an M.D. in alternative medicine at IBAM, India. In 2016, he received a Ph.D. in adipose-derived stem cell research at Westminster University in Korea.

Gilani is the Founder, CEO and Stem Cell/Regenerative Medicine Consultant for The Institute of Regenerative Medicine in Rawalpindi, Pakistan, the first-of-its-kind regenerative medicine institute in Pakistan that caters to clinical applications of stem cell and other regenerative medicine treatments. The institute also serves as a center of excellence in training physicians and paramedic staff in regenerative medicine in Pakistan.

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

Syed Salman Naeem Gilani, M.D.

In 2000, Gilani received his medical degree from Rawalpindi Medical College, Punjab University and completed a Fellowship in Stem Cell Therapy from the American Board of Anti-aging and Regenerative Medicine. He is ECFMG certified, a member of the American Academy of Anti-Aging and Regenerative Medicine, and a Diplomat of the American Academy of Aesthetic Medicine.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

ISSCA names R. Gökmen Turan M.D., Ph.D., and Mahir Mahirogullari, M.D. keynote speakers at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.

MIAMI, March 18, 2018— R. Gökmen Turan M.D., Ph.D. and Mahir Mahirogullari, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Turan will speak on therapeutic applications of stem cells in heart failure, and Mahirogullari will discuss cartilage treatment combining stem cells and biomedical scaffolds.

R. Gökmen Turan M.D., Ph.D.

R. Gökmen Turan M.D., Ph.D.

Turan is a cardiologist and head of the Structural Heart Disease Department of Internal Medicine, Division of Cardiology at Porz Hospital, University Hospital of Cologne and University of Witten/Herdecke Germany.

Mahirogullari is an orthopedic surgeon specializing in sports medicine and traumatology.  He currently serves as a professor at Memorial Health Group in İstanbul, Turkey.

His focus includes multi-ligament injuries and cartilage repair of the knee; arthroplasty of the knee, hip and shoulder; arthroscopy of the knee, shoulder, hip, ankle and elbow joints; surgery of instability and cuff tear of the shoulder; orthopedic trauma, and the application of platelet-rich plasma (PRP), bone marrow aspirate stem cells and adipose-derived stem cells for treatment of orthopedic pathologies especially cartilage injuries.

Mahir Mahirogullari. M.D.

Mahir Mahirogullari. M.D.

Mahirogullari received his medical degree (M.D.) from Gülhane Military Medical Academy School of Medicine in Ankara, Turkey in 1992 and completed his residency at GATA Haydarpasa Training Hospital in Istanbul.

He served as a general practitioner and orthopedic surgeon, treating and managing multi-trauma patients and war injuries. He also served with KFOR, NATO in Kosovo for six months. He worked as a Fellow with arthroscopic shoulder, knee, and trauma specialist Gary G. Poehling, M.D. in Winston Salem, North Carolina for one year before joining the faculty at Istanbul Medipol University School of Medicine in 2012 as chairman of the Department of Orthopedic Surgery. He has worked within the Memorial Health Group in Istanbul since 2016.

Mahirogullari is a member of The Turkish Society of Orthopedics and Traumatology (TOTBİD), The Turkish Society of Arthroscopy Knee Surgery & Orthopedics Sport Medicine (TUSYAD), The International Society of Arthroscopy Knee Surgery & Orthopedics Sport Medicine (ISAKOS),  The Turkish Society of Shoulder and Elbow Society, The European Society of Sports Traumatology Knee Surgery and Arthroscopy (ESSKA 2000), The Turkish Board Certificate,  and The Turkish Society of Hip and Knee Arthroplasty.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

R. Gökmen Turan M.D., Ph.D. and Mahir Mahirogullari, M.D.

Bogota Colombia

 

 

 

 

 

 


Image: Bogota, Colombia

ISSCA will conduct the next hands-on regenerative medicine certification training course for physicians in Bogota, Colombia May 25-26, 2018.

MIAMI, Nov. 20, 2017—The International Society for Stem Cell Application (ISSCA) announced plans to hold its next hands-on regenerative medicine certification training course for physicians in Bogota, Colombia May 25-26, 2018.

Plans for the next training workshop follow the success of the organization’s first Bogota-based course held March 2-3, 2018 and attended by eight physicians from three countries—Spain, Colombia, and Ecuador.

stem cell training Bogota

Stem cell training

The two-day, intensive training course teaches participating physicians how to harvest stem cells from adipose and bone marrow tissue. Participants learn while they conduct regenerative medicine protocols on live patients under the direction of stem cell training experts. Skills learned in the training course can be used to treat a variety of medical and aesthetic conditions such as osteoarthritis and facial rejuvenation.

Once certified, practitioners learn can use the techniques learned to treat patients in their practices and in clinical settings for career advancement. The course provides participating physicians with access to ISSCA’s online stem cell training course to review all content and procedures introduced during the two-day clinical training course, as well as patient forms and guidelines, procedures, informed consent forms, didactic lectures, training booklets, and more.

The ISSCA regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from patients’ adipose tissue and bone marrow.

Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.

Seating for this training course is limited. Register today to participate by visiting the Stem Cell Training Course Bogota website, email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

Stem cell training Bogota

 

 

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

 

 

 

 

 

 

 

ISSCA announces keynote speakers Mehmet Veli Karaaltın, M.D. and Mehmet Bozkurt, M.D. at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28.

MIAMI, March 18, 2018— Mehmet Veli Karaaltın M.D. and Mehmet Bozkurt, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Karaaltın will speak on the role of cellular therapy and futuristic applications in plastic reconstructive surgery: from anti-aging to reconstructive surgery (level evidence IV). Bozkurt will discuss the application of regenerative cells on immunologic and diabetic wounds and severe burns.

Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D.

Mehmet-Veli-Karaaltın, M.D.

Karaaltın, a Global Stem Cells Group advisory board member, specializes in head and maxillofacial surgery and hand surgery, and serves as an associate professor of plastic aesthetic & reconstructive surgery (European Board Certified) at Hacettepe University Medical Faculty in Ankara, Turkey.

After graduating from Istanbul University’s Cerrahpaşa English Medical Faculty, Karaaltın completed a national examination from Hacettepe University in Ankara, Turkey, placing 12th out of 25,000 doctoral candidates. He later completed all exam requirements of the European Society of Plastic Surgery. He is a member of the European Council of Plastic Reconstructive and Aesthetic Surgery and the International Society of Aesthetic Plastic Surgery (ISAPS).

In addition to his work in aesthetic applications, Karaaltın is also known for his work in microvascular free flaps, nerve transfers, facial surgery, and tissue transplants. He also practices cellular therapy and tissue regeneration for healing diabetic wounds, severe burns, and Buerger’s disease. He is one of only a few physicians in the world who offer surgical treatment for Lymphedema-Elephant Disease with microvascular lymph node transfer.

Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D.

Mehmet Bozkurt, M.D.

Bozkurt is a plastic and reconstructive surgeon and serves as chairman and director of the plastic reconstructive surgery and burn center at Kartal Dr. Lütfi Kırdar Training and Research Hospital in Istanbul. He completed his clinical fellowship in microsurgery at Cleveland Clinic in 2012. Bozkurt is a member of The International Federation for Adipose Therapeutics and Science, The İnternational Society of Burn Association, and The Turkish Aesthetic Surgery Association. He is board certified in European plastic surgery and Turkish plastic surgery.

He completed medical school in July 1995 at the Gulhane Military Medical Academy Faculty of Medicine in Ankara, Turkey and completed post-graduate studies and training in emergency medicine, microsurgery, plastic and reconstructive surgery, orthopedic medicine, and preventative medicine. He is the recipient of numerous honors and awards in his field.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D.

AAPE products

Global Stem Cells Group  affiliate Adimarket is named official distributor of Prostemics’ advanced adipose-derived stem cell protein extract (AAPE) biologic products.

MIAMI, March 18, 2018—Global Stem Cells Group subsidiary Adimarket has been named the official distributor of advanced adipose-derived stem cell protein extract (AAPE) products manufactured by Prostemics.

AAPE hair and skin care products, available through Adimarket’s online regenerative medicine store, leverage the regenerative power of stem cells for use in anti-aging and restorative skin and hair products by utilizing medical techniques to extract, manipulate, and process adipose-derived stem cells.

AAPE product benefits:

Skin care

AAPE productsMore than 800 types of human protein extracts in stem cells provide superior biological activity to boost cell repair and improve skin elasticity that is lost in the natural aging process. AAPE can be applied in various areas of clinical treatment with MTS and laser for anti-wrinkle, anti-oxidation, wound healing, and whitening effects. In Japan, more than 200 dermatologic clinics use AAPE for skin rejuvenation. AAPE is approved by dermatologists and medical professionals in the U.S., Korea, and Japan. Since it is extracted from human adipose-derived stem cells, AAPE is considered very safe, effective, and powerful for anti-aging skin care regimens.

Hair care:

AAPE productsAAPE hair care serum is a non-invasive treatment that can be applied in a clinical setting without discomfort or downtime as a hair loss treatment.

The serum’s adipose or fat tissue content provides large numbers of mesenchymal stem cells (MSCs) which are located within the stromal vascular fraction (SVF) which contains powerful regenerative stem and stromal cells, progenitor cells, growth factors and many other powerful biologic components that work to regenerate cell growth.

AAPE hair treatments can be used with PRP or Platelet Rich Plasma. Like PRP, recent scientific literature supports the use of adipose-derived stem cells to help enhance hair growth from weak hair follicles.

About Adimarket:

Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.

Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.

###

AAPE products

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

 

 

 

 

 

 

 

ISSCA announces keynote speakers Abdul Majeed, M.D. and Hilmi Karadeniz, M.D. at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.

MIAMI, March 18, 2018—Abdul Majeed, M.D. and Hilmi Karadeniz, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Majeed will discuss findings of a recent study on intra-arterial injection of autologous bone marrow-derived mononuclear cells in ischemic stroke patients. Karadeniz will speak on current approaches to the application of regenerative treatments in athletes.

Abdul Majeed, M.D.

Abdul Majeed, M.D.

Majeed is a hematologist, consultant, FRCP London, and a pioneer in stem cell transplantation and stem cell therapies in Iraq. He heads Global Stem Cells Group affiliate Stem Cell Centre in Baghdad. In 1992, he obtained a degree from the Board of Internal Medicine and served as the head of the medicine department Bin Majid hospital in Basra, southern Iraq.

In 2004, Majeed invited Prof. Marino Andolina (a pediatric immunologist from Trieste Italy) to Baghdad to perform the first autologous bone marrow transplant in Iraq. In 2009, Majeed and his team in Iraq began providing bone marrow-derived stem cell therapy for spinal cord injuries, multiple sclerosis, muscular dystrophy, and other medical conditions. He served as director of the bone marrow transplantation unit at the medical city hospital in Baghdad from 2011 to 2017.

Hilmi Karadeniz, M.D.

Hilmi Karadeniz, M.D.

Karadeniz specializes in orthopedics and traumatology including sports medicine and surgery, arthroplasty, trauma surgery, spinal surgery, and ultrasound-guided PRP applications.

He studied at Istanbul School of Medicine, Istanbul University from 1998 – 2004, and Orthopedics and Traumatology Clinic II, Istanbul Research and Training Hospital, Ministry of Health from 2005 – 2011. Karadeniz currently serves as an orthopedic surgeon and traumatologist at Şişli Kolan Hospital in Istanbul.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

 

Abdul Majeed, M.D. and Hilmi Karadeniz, M.D.

 

 

 

 

 

 

MIAMI, Feb 19, 2018—Amine Rafik, M.D., Ph.D., a member of the Global Stem Cells Group Advisory Board, will be a keynote speaker at the International Association for Stem Cell Application (ISSCA) Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Rafik will speak on the role of adipose-derived stem cells in regenerative medicine as an attractive alternative to the use of stem cells derived from bone marrow and other sources, due to their abundance in fat and their ability to be easily harvested.

Amine Rafik, M.D., Ph.D

Rafik will present a retrospective review of patients treated for leg ulcers with lipofilling between 2011 –  2014 at the National Centre for Burns and Plastic Surgery, University Hospital. Ibn-Rochd Casablanca, Morocco.

Rafik’s lecture will include patient demographic data and digital photographs taken on the day of each patient’s surgery and every day thereafter. ASC patients received three treatments of 20 cc of autologous adipose stem cell injections in the subcutaneous tissue surrounding the ulcer with time to wound closure defined as the time at which the wound bed was completely re-epithelialized and filled with new tissue.

He will discuss study results revealing the average time for wound closure in adipose stem cell (ASC) recipient patients compared to control group patients. He will also examine the study’s conclusion that suggests local transplantation of autologous adipose stem cells could accelerate wound healing, and that some clinical aspects of wound healing, as well as the potential for therapies based on stem cells, represent a feasible therapeutic approach to the treatment of clinical wounds.

Rafik is a consultant and plastic, reconstructive and aesthetic surgeon at Al Farabi Hospital in Morocco. He specializes in reconstructive plastic surgery particularly for the face, head, and neck, as well as for patients who require reconstructive surgery following treatment for skin cancer or trauma. Rafik also performs cosmetic surgery and microsurgery.

He completed his plastic surgery training in Casablanca and was awarded full membership to the American Academy of Cosmetic Surgery in 2015, and the European Association of Maxilla-Facial surgery in 2016.

He is a reviewer for many international indexed journals, including; OncoTargets and Therapy Journal, the British Journal of Medicine and Medical Research, and the Cancer and Clinical Oncology Journal, published by Canadian Center of Science and Education, where he is a member of the editorial board.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today.

For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA conference speaker Amine Rafik

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

 

 

 

 

 

 

 

ISSCA Istanbul conference: The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium at the Hotel Hyatt Regency in Istanbul, Turkey April 28, 2018.

MIAMI, Feb 19, 2018—The International Association for Stem Cell Application (ISSCA) will host its next regenerative medicine symposium at the Hotel Hyatt Regency in Istanbul, Turkey April 28, 2018.

The symposium agenda will focus on:

  • Molecular biology
  • Clinical advances in stem cell research
  • Models of treatment in surgical and cosmetic applications, and in clinical conditions
  • Technological advances
  • Application of minimally manipulated stem cells in the physician’s office
  • Stem cells, regenerative medicine and its application in anti-aging medicine, Pain Management and Orthopedics
  • Medical legal issues.
  • Regulatory Pathways

Istanbul, the economic, cultural, and historic center of Turkey, is the country’s most populous city. The luxurious Hotel Hyatt Regency, located near Istanbul’s Ataturk Airport, offers visitors the combination of comfort, culture, and convenience for exploring the ancient city. Symposium attendees will be able to discover sights such as the Blue Mosque and the Hagia Sophia.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine, and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today.

For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cells Applications

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA Istanbul conference

 

 

 

 

 

 

 

 

MIAMI, Feb 19, 2018—Leslie Mesen, M.D., a leader in the field of anti-aging medicine in Latin America and medical director of Global Stem Cells Group affiliate Stem Cell Center in Escazu, Costa Rica, will be a keynote speaker at the International Association for Stem Cell Application (ISSCA) Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018.

ISSCA Leslie Mesen

Leslie Mesen, M.D.

Mesen will present a lecture detailing the wound-healing potential of mesenchymal stem cell procedures—both SVF and BMAC—in wounds when no other treatment options exist. Mesen will discuss his experience successfully treating a serious foot wound using mesenchymal stem cells in a 45-year-old patient. The wound was the result of a 30.000-volt shock caused when the patient came in contact with a high-tension power line. The shock traveled down the patient’s leg and exited through his left foot, leaving the wound and underlying structure exposed.

Three months post-injury, the patient’s foot wound was not healing. Mesen administered an SVF autologous stem cell procedure and, four-weeks post-stem cell treatment, the wound showed significant improvement (70 percent wound closure) with clear new tissue growth visible around the wound. Mesen then performed an activated PRP procedure to further stimulate cell division.

Two weeks after the PRP treatment, the patient was walking in shoes, and underwent a final stem cell procedure. Over a period of five weeks, the patient—an electrician– recovered the ability to care for himself. He is expected to return to work soon.

Mesen is board certified in anti-aging and regenerative medicine by The American Academy of Anti-Aging Medicine and a pioneer in anti-aging medicine in Latin America.

He has extensive experience as the chief medical officer of three highly recognized anti-aging institutes: Costagenics Age Management program (2007-2010), Anti-Aging Institute of the Americas (2010-2013) and the Anti-Aging and Wellness Clinic (2014- present).

Mesen studied medicine at Universidad Iberoamericana (UNIBE) in San José, Costa Rica and receives continuing education courses in the United States and Latin America. In the U.S., he has trained at the University of Miami Jackson Memorial Hospital. His range of services encompass all aspects of aging, delivering programs tailored to each patient’s unique needs. Mesen offers platelet-rich plasma (PRP) therapy, HRT, hair regrowth treatments, intravenous infusions, and a range of other anti-aging and aesthetic treatments.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today.

For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine

and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA Leslie Mesen